Treatment of Malignant Diseases

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP10180033.2

公开号：

EP2433636A1

申请日:

2010.09.27

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

The invention discloses a compound selected from the group N*2*,N*4*-Bis-(2-methyl-1H-indol-5-yl)-pyrimidine-2,4-diamine, N*2*-(4-Diethylamino-1-methyl-butyl)-5-methyl-N*4*-(2-methyl-1H-indol-5-yl)-pyrimidine-2,4-diamine, N*2*,N*4*-Bis-(1H-indol-5-yl)-pyrimidine-2,4-diamine and N*2*-(1H-Indol-6-yl)-N*4*-(1H-indol-5-ylmethyl)-pyrimidine-2,4-diamine, preferably N*2*,N*4*-Bis-(2-methyl-1H-indol-5-yl)-pyrimidine-2,4-diamine,and any of its stereoisomeric forms or a mixture thereofor a salt or solvate of a compound of these compounds, especially for use in the treatment of malignant diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/